APA (7th ed.) Citation

F, N., M, B., R, G., P, F., A, F., S, R., . . . D, R. (2024). Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study). British journal of haematology, 205(2), 495. https://doi.org/10.1111/bjh.19459

Chicago Style (17th ed.) Citation

F, Nguyen-Khac, et al. "Prognostic Impact of Genetic Abnormalities in 536 First-line Chronic Lymphocytic Leukaemia Patients Without 17p Deletion Treated with Chemoimmunotherapy in Two Prospective Trials: Focus on IGHV-mutated Subgroups (a FILO Study)." British Journal of Haematology 205, no. 2 (2024): 495. https://doi.org/10.1111/bjh.19459.

MLA (9th ed.) Citation

F, Nguyen-Khac, et al. "Prognostic Impact of Genetic Abnormalities in 536 First-line Chronic Lymphocytic Leukaemia Patients Without 17p Deletion Treated with Chemoimmunotherapy in Two Prospective Trials: Focus on IGHV-mutated Subgroups (a FILO Study)." British Journal of Haematology, vol. 205, no. 2, 2024, p. 495, https://doi.org/10.1111/bjh.19459.